As part of GTCRs Leaders StrategyTM, we seek to identify and partner with talented, accomplished executives with whom we work collaboratively to build and grow our portfolio companies. para informarnos de que tienes problemas. Biocoat's custom hydrophilic coatings are lubricious, abrasion resistant, biocompatible and can be applied to a wide range of polymeric and metallic substrates. Before that Jim played a leadership role in the growth and evolution of Wind Point Partners, a Chicago-based middle market private equity firm, over 19 years and five private equity funds. PDF Platforms Add-ons 14b+ GTCR - Funding, Financials, Valuation & Investors +1-312-933-4903 The firm principally invests in high-growth industries, including financial services & technology, healthcare, information services & technology, and growth business services. To explore GTCRs full profile, request access. Ironshore Insurance provides broker-sourced specialty property and casualty insurance coverages for varying risks. GTCR LLC is setting a higher goal for its latest flagship buyout fund despite a challenging fundraising environment. GTCR is a leading growth-oriented private equity firm with a management-driven approach and business-building investment orientation. Riverside Signs Definitive Agreement to Sell Lexipol Since its inception, GTCR has invested more than $20 billion in over 250 companies. Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Business & Consumer Services, Financial Services & Technology, Healthcare, and Technology, and Media & Telecommunications industries. The Chicago-based firm pioneered - finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions. GTCR Investor Profile: Portfolio & Exits | PitchBook GTCR has a longstanding relationship with Mr. Hance, having originally partnered with him to form Regatta Medical in 2017 as a Leaders Strategy partnership to pursue opportunities in the medical device industry and acquired Resonetics, a leading medical device contract manufacturer, in February 2018. GTCR Announces Strategic Investment from Blackstone GP Stakes Blackstone Contact: Funding. GTCR Appoints Don McDonough to Lead Business Development for its I have been personally gratified to develop rapport with the GTCR team, and we look forward to our long-term partnership., Ward Young, GP Stakes Managing Director added, Our top priority is to partner with the most successful general partners in private equity. Chicago, from 8 AM - 9 PM ET. CHICAGO and NASHVILLE, Tenn., May 13, 2022 /PRNewswire/ --. Allspring Global Investments Commences Operations As an Independent We do this by using extraordinary people and flexible capital to help companies solve problems. Portions of this site are directed only to persons in certain jurisdictions. Since its inception, GTCR has invested more than $20 billion in over 250 companies. enva un correo electrnico a envie um e-mail para Simpli.fi is a demand side platform transforming unstructured data elements to valuable factors that aid in decision making. Blackstones GP Stakes business specializes in value-added, long-term partnerships with leading private-market alternative asset management firms. We are pleased to support GTCRs ongoing success.. GTCR Announces Strategic Investment in Senske Services Kellie Kennedy, Harbinger Group +1-347-463-5453 Get the full list, Riverchase Dermatology and Cosmetic Surgery, Youre viewing 5 of 255 exits. Financial Advisors, visit our dedicated website to learn how you can partner with Blackstone. Prior to partnering with GTCR, Mr. Hance served as Chief Executive Officer of Creganna Medical, a leading supplier of contract manufacturing services for medical devices, where he significantly grew the business via acquisitions and organic growth before completing a successful sale of the company in 2016 to TE Connectivity. Deep Sector Expertise | Portfolio Company Investments - GTCR We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. The Company's capabilities include developing and supplying customized coatings formulations, performing coatings application services, and offering coatings equipment solutions. 60654 GTCR is a private equity firm that typically partners with management when pursuing acquisitions. By submitting this request, you consent to receive email from Blackstone. Leaders Strategy Investment to Support Growth and Expansion of Biocompatible Medical Device Coatings Provider. Type: Company - Private. Which industries has this organization had the most exits in? Illinois Venture Capital Association (IVCA2), Youre viewing 5 of 800 investments and acquisitions. GTCR is a prolific health care investor, with at least 11 current health care portfolio companies and almost 50 past investments. questo messaggio, invia un'email all'indirizzo PitchBooks data visualizations quickly surface an investors historical investmentsshowing a breakdown of activity by industry, year and region. The terms of the transaction were not disclosed. This website uses cookies, including third-party cookies, in order to obtain information about your visit to the website and make this website better. Aydanos a proteger Glassdoor y demustranos que eres una persona real. Further information is available at www.blackstone.com. info@gtcr.com. The Chicago-based firm is targeting $9.5 billion for GTCR Fund XIV, which will take control positions in companies across the healthcare, business services, financial services and technology industries, according to documents prepared for Maine Public Employees Retirement System. GTCR LLC | 12,402 followers on LinkedIn. Follow us on LinkedIn. Watch the 40th Anniversary video Our Team A highly resourceful team of professionals with a relentless drive to get results. On behalf of the Managing Directors of GTCR, Collin Roche and Dean Mihas released a statement: We are thrilled to have this opportunity to work with Blackstone as a passive minority investor in our firm. How many investments has this organization made over time? GTCR Mergers and Acquisitions Summary | Mergr I have known the GTCR team for nearly a decade and we share a common vision and commitment to building PathGroup into a larger, more diversified business that can better serve our providers and their patients. Sie weiterhin diese Meldung erhalten, informieren Sie uns darber bitte per E-Mail PathGroup uses the latest in proprietary and industry standard technology to deliver fast, accurate results. GTCR is the current iteration of an equity and investment corporate finance entity dating back to the 1970s. Piper Sandler served as exclusive financial advisor to Biocoat. Our $684 billion in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, life sciences, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. GTCR was formed in 1980 and is based in Chicago, Illinois. This platform enables the Company to work with its customers across a wide range of interventional products and medical device segments, including neurovascular, ophthalmology, cardiovascular and other interventional specialties. In 1998, disagreements between the senior partners led Golder, Thoma, Cressey, Rauner, Inc. split into two private equity firms. Since its inception, GTCR has invested more than $24 billion in over 270 companies, and the firm currently manages over $27 billion in equity capital. GTCR - Investments, Portfolio & Company Exits - CrunchBase TheChicago-based firm pioneered The Leaders Strategy - finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. (312) 382-2200 Kirkland & Ellis served as legal counsel to GTCR and Fried Frank served as legal counsel to Blackstone. The firm has a world-class group of leaders and investment professionals, a differentiated investment approach and a long history of success. Chicago-based private equity firm GTCR is considering a sale of TerSera Therapeutics LLC that could value the specialty pharmaceutical company at more than $1 billion, according to people familiar . As part of GTCR's Leaders Strategy, Dave King, the former Chairman and CEO of Labcorp, will join the PathGroup Board as Chairman, partnering with Dr. Davis and GTCR to further invest in PathGroup's capabilities across the pathology, molecular, and genetic diagnostics modalities. Founded in 1980, GTCR is a leading private equity firm that pioneered The Leaders Strategy finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through organic growth and strategic acquisitions. Kirkland & Ellis served as legal counsel to GTCR and Fried Frank served as legal counsel to Blackstone. Kirkland & Ellis LLP served as legal counsel and Baird served as financial advisor to GTCR. Follow us onLinkedIn. For more information, please visitwww.gtcr.com. GTCR 300 N. LaSalle Street, Suite 5600, Chicago, Illinois 60654 United States (312) 382-2200 www.gtcr.com info@gtcr.com Profile M&A Activity (207) Portfolio (131) Team (41) Offices (1) M&A Connections (79) M&A Advisors (41) Analytics GTCR is a private equity firm that typically partners with management when pursuing acquisitions. The partnership will provide GTCRs portfolio companies with access to Blackstones group purchasing program, which leverages the buying power of the $150 billion revenue base across Blackstones entire investment platform. The Company's capabilities include developing and supplying customized coatings formulations, performing coatings application services, and offering coatings equipment solutions.